Unique Retinol Therapy with Antioxidant and Anti-Inflammaging Complex for Naturally Reborn Skin: The Clinical Case Series Study
Table 1
Patients’ subjective assessment of facial skin symptom changes.
P (n = 5)
S (n = 5)
NSS (n = 5)
Summary (n = 15)
Redness
Yes
1 (20.0%)
2 (40.0%)
3 (75.0%)
6 (42.9%)
Slightly
2 (40.0%)
3 (60.0%)
0 (0.0%)
5 (35.7%)
No
2 (40.0%)
0 (0.0%)
1 (25.0%)
3 (21.4%)
Skin tone
Yes
4 (80.0%)
4 (80.0%)
4 (80.0%)
12 (80.0%)
Slightly
1 (20.0%)
1 (20.0%)
1 (20.0%)
3 (20.0%)
No
0 (0.0%)
0 (0.0%)
0 (0.0%)
0 (0.0%)
Skin pigmentation reduction
Yes
4 (80.0%)
4 (80.0%)
4 (80.0%)
12 (80.0%)
Slightly
1 (20.0%)
1 (20.0%)
1 (20.0%)
3 (20.0%)
No
0 (0.0%)
0 (0.0%)
0 (0.0%)
0 (0.0%)
Skin pigmentation liquidation
Yes
1 (20.0%)
3 (75.0%)
2 (40.0%)
6 (42.9%)
Slightly
3 (60.0%)
1 (25.0%)
1 (20.0%)
5 (35.7%)
No
1 (20.0%)
0 (0.0%)
2 (40.0%)
3 (21.4%)
Dehydration
Yes
3 (60.0%)
3 (60.0%)
4 (80.0%)
10 (66.7%)
Slightly
1 (20.0%)
1 (20.0%)
0 (0.0%)
2 (13.3%)
No
1 (20.0%)
1 (20.0%)
1 (20.0%)
3 (20.0%)
Dryness
Yes
2 (40.0%)
3 (75.0%)
4 (80.0%)
9 (64.3%)
Slightly
2 (40.0%)
1 (25.0%)
0 (0.0%)
3 (21.4%)
No
1 (20.0%)
0 (0.0%)
1 (20.0%)
2 (14.3%)
Wrinkle reduction
Yes
2 (40.0%)
3 (60.0%)
0 (0.0%)
5 (33.3%)
Slightly
3 (60.0%)
2 (40.0%)
2 (40.0%)
7 (46.7%)
No
0 (0.0%)
0 (0.0%)
3 (60.0%)
3 (20.0%)
Wrinkle liquidation
Yes
0 (0.0%)
2 (40.0%)
0 (0.0%)
2 (13.3%)
Slightly
2 (40.0%)
3 (60.0%)
0 (0.0%)
5 (33.3%)
Nie
3 (60.0%)
0 (0.0%)
5 (100.0%)
8 (53.4%)
Structure
Yes
5 (100.0%)
4 (80.0%)
3 (60.0%)
12 (80.0%)
Slightly
0 (0.0%)
1 (20.0%)
2 (40.0%)
3 (20.0%)
No
0 (0.0%)
0 (0.0%)
0 (0.0%)
0 (0.0%)
Sebaceous gland activity
Yes
3 (60.0%)
3 (60.0%)
3 (60.0%)
9 (60.0%)
Slightly
0 (0.0%)
1 (20.0%)
2 (40.0%)
3 (20.0%)
No
2 (40.0%)
1 (20.0%)
0 (0.0%)
3 (20.0%)
Scar reduction
Yes
1 (33.3%)
1 (25.0%)
2 (40.0%)
4 (33.3%)
Slightly
0 (0.0%)
0 (0.0%)
0 (0.0%)
0 (0.0%)
No
2 (66.7%)
3 (75.0%)
3 (60.0%)
8 (66.7%)
Scar liquidation
Yes
0 (0.0%)
0 (0.0%)
1 (20.0%)
1 (9.1%)
Slightly
1 (33.3%)
0 (0.0%)
0 (0.0%)
1 (9.1%)
No
2 (66.7%)
3 (100.0%)
4 (80.0%)
9 (81.8%)
Overall improvement
Yes
5 (100.0%)
5 (100.0%)
5 (100.0%)
15 (100.0%)
Slightly
0 (0.0%)
0 (0.0%)
0 (0.0%)
0 (0.0%)
No
0 (0.0%)
0 (0.0%)
0 (0.0%)
0 (0.0%)
After which series improvement was noticed
1
0 (0.0%)
2 (40.0%)
1 (20.0%)
3 (20.0%)
2
3 (60.0%)
3 (60.0%)
2 (40.0%)
8 (53.3%)
3
2 (40.0%)
0 (0.0%)
2 (40.0%)
4 (26.7%)
After which series skin peeling was noticed
1
0 (0.0%)
1 (20.0%)
0 (0.0%)
1 (7.7%)
2
2 (40.0%)
2 (40.0%)
2 (66.7%)
6 (46.2%)
3
1 (20.0%)
0 (0.0%)
1 (33.3%)
2 (15.4%)
1, 2, 3
2 (40.0%)
2 (40.0%)
0 (0.0%)
4 (26.7%)
1, 3
0 (0.0%)
0 (0.0%)
1 (20.0%)
1 (6.7%)
2, 3
0 (0.0%)
0 (0.0%)
1 (20.0%)
1 (6.7%)
P: patients with superficial and deep hyperpigmentation, S: patients with mature skin with first signs of aging, NSS: patients with postinflammatory hyperpigmentation, atrophic acne scars, and enlarged pores.
